Bicocca Open Archive

Logo unimib boa
SMITH, ANDREW
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.219
AS - Asia 8.463
EU - Europa 6.524
SA - Sud America 1.058
AF - Africa 104
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
Totale 26.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.951
VN - Vietnam 2.541
SG - Singapore 2.536
IT - Italia 2.029
CN - Cina 1.684
HK - Hong Kong 985
DE - Germania 861
BR - Brasile 851
RU - Federazione Russa 850
SE - Svezia 651
IE - Irlanda 637
GB - Regno Unito 346
AT - Austria 248
UA - Ucraina 180
CA - Canada 177
FR - Francia 159
IN - India 151
NL - Olanda 100
DK - Danimarca 92
FI - Finlandia 90
KR - Corea 90
ID - Indonesia 88
AR - Argentina 78
TR - Turchia 70
MX - Messico 61
JP - Giappone 59
ES - Italia 58
PL - Polonia 52
BD - Bangladesh 50
ZA - Sudafrica 48
EC - Ecuador 39
IQ - Iraq 32
BE - Belgio 31
PY - Paraguay 24
CH - Svizzera 22
AU - Australia 21
LT - Lituania 21
PK - Pakistan 19
SA - Arabia Saudita 18
IR - Iran 16
PE - Perù 16
TW - Taiwan 16
CZ - Repubblica Ceca 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 14
CO - Colombia 14
TH - Thailandia 13
MA - Marocco 11
UY - Uruguay 11
UZ - Uzbekistan 11
GR - Grecia 10
IL - Israele 10
RO - Romania 10
NO - Norvegia 9
PT - Portogallo 9
DZ - Algeria 8
EG - Egitto 8
JO - Giordania 8
MY - Malesia 8
HR - Croazia 7
TN - Tunisia 7
BG - Bulgaria 6
KE - Kenya 6
KZ - Kazakistan 6
PH - Filippine 6
AL - Albania 5
BO - Bolivia 5
CL - Cile 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
JM - Giamaica 5
LV - Lettonia 5
NP - Nepal 5
PA - Panama 5
AZ - Azerbaigian 4
HN - Honduras 4
LB - Libano 4
OM - Oman 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
KW - Kuwait 2
NG - Nigeria 2
PS - Palestinian Territory 2
SC - Seychelles 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BT - Bhutan 1
CI - Costa d'Avorio 1
EE - Estonia 1
Totale 26.377
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.699
Singapore 1.464
Ashburn 1.027
Hong Kong 963
Ho Chi Minh City 780
Milan 762
Dublin 623
Hanoi 586
Fairfield 584
Chandler 581
Frankfurt am Main 550
Wilmington 460
Woodbridge 365
New York 352
Houston 334
Dearborn 306
Santa Clara 294
Seattle 259
Dallas 258
Beijing 240
Los Angeles 234
Vienna 208
Hefei 201
Princeton 191
Cambridge 184
Shanghai 156
Jacksonville 147
Nanjing 134
Dong Ket 111
São Paulo 107
Moscow 90
Buffalo 89
The Dalles 76
Seoul 74
Ha Long 71
Chicago 68
Da Nang 68
Rome 68
Quận Bình Thạnh 61
Jakarta 59
Kent 59
Hải Dương 56
Haiphong 54
London 54
Guangzhou 53
Lawrence 49
Biên Hòa 48
Council Bluffs 46
Nanchang 46
Munich 43
Thái Nguyên 43
Helsinki 42
Nuremberg 42
Toronto 42
Altamura 41
Shenyang 40
Brooklyn 37
Can Tho 37
Denver 37
Falls Church 37
Lissone 37
Tokyo 37
Vũng Tàu 37
Montreal 36
Warsaw 36
San Diego 35
Atlanta 33
Fremont 32
Ninh Bình 32
Bắc Ninh 31
Chennai 31
Poplar 31
Stockholm 31
Bắc Giang 29
Hebei 29
Andover 28
Changsha 28
Salt Lake City 28
Florence 27
Ottawa 27
Phoenix 27
Quận Phú Nhuận 27
Zhengzhou 27
Brussels 26
Orem 26
Manchester 25
Johannesburg 24
Quận Một 24
Boardman 23
Pune 23
Phủ Lý 22
Rio de Janeiro 22
San Jose 22
Amsterdam 21
Belo Horizonte 21
Boston 21
Jiaxing 21
Jinan 21
Pavia 21
Naples 19
Totale 16.888
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 543
Viewing coffee fine roots under a molecular lens: Mapping the distribution of relevant metabolites by MALDI-MS imaging 536
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 484
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 468
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 431
MALDI mass spectrometry imaging shows a gradual change in the proteome landscape during mouse ovarian folliculogenesis 420
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 403
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 389
The putative role of MALDI-MSI in the study of Membranous Nephropathy 386
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 379
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 354
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 353
MALDI imaging in Fabry nephropathy: a multicenter study 351
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 349
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 346
The proteomic landscape of renal tumors 345
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 335
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 329
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 317
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 317
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 317
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 316
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 313
Proteomics for the diagnosis of thyroid lesions: Preliminary report 310
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 310
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 310
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 305
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 303
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 302
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 291
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 285
Proteomics for the study of new biomarkers in Fabry disease: State of the art 284
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 277
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 277
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 271
Tumor size, stage and grade alterations of urinary peptidome in RCC 269
Proteome analysis in thyroid pathology 268
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 265
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 262
A molecular imaging approach to individuate tumour infiltrating lymphocytes 249
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 246
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 244
Intraluminal proteome and peptidome of human urinary extracellular vesicles 243
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 240
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 240
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 239
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 236
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 227
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 226
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 213
The role of fine needle aspiration of orbital lesions: A case series 213
Single-follicle spatial proteomics of the whole ovary by MALDI mass spectrometry imaging: towards the identification of protein-markers of the follicle's quality 211
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 210
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 209
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 209
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 207
Machine learning approaches in MALDI-MSI: clinical applications 201
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 200
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 198
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 196
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 196
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 196
MALDI-MS imaging in the study of glomerulonephritis 191
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 191
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 189
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 183
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 179
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 175
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 172
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 171
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 168
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 167
The putative role of MALDI-MSI in the study of Membranous Nephropathy 163
The putative role of MALDI-MSI in the study of Membranous Nephropathy 161
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 158
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 156
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 154
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 153
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 150
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 149
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 149
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 147
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 147
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 146
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 145
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 142
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 142
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 139
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 138
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 137
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 136
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 135
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 133
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 131
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 127
The Reed-Stanton press rig for the generation of reproducible fingermarks: Towards a standardised methodology for fingermark research 127
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 122
α-1-antitrypsin detected by MALDI-Imaging in the study of glomerulonephritis: its relevance in chronic kidney disease progression 122
Precision medicine for Diabetic Nephropathy and Hypertensive Nephrosclerosis 117
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 116
Totale 24.147
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.370 0 0 0 0 0 233 191 256 154 169 124 243
2021/20221.493 119 144 91 162 114 145 39 83 61 113 149 273
2022/20232.579 300 692 242 199 101 394 47 200 172 37 113 82
2023/20242.140 75 85 82 145 198 585 438 52 132 36 82 230
2024/20255.111 226 452 344 214 439 183 310 196 600 785 567 795
2025/20269.113 2.847 1.521 1.056 1.547 1.540 602 0 0 0 0 0 0
Totale 27.328